Overview
Public Biotech
Clinical-stage biotech with Phase 3 NDV-01 for bladder cancer and sepranolone for Tourette's syndrome. Previously focused on esmethadone for depression before strategic pivot.
Visit WebsiteCoral Gables, FL
$45M
Market Cap
2004
Founded
0
Open Roles
Open Positions
No open positions at this time
Clinical Pipeline
No clinical trials on record